Feeds:
Posts
Comments

Archive for the ‘Lemelson-MIT Prize’ Category

AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders

AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders

Curator: Aviva Lev-Ari, PhD, RN

We had researched the topic of AI Initiatives in Big Pharma in the following article:

  • Authentic Relevance of LPBI Group’s Portfolio of IP as Proprietary Training Data Corpus for AI Initiatives at Big Pharma

https://pharmaceuticalintelligence.com/2025/11/15/authentic-relevance-of-lpbi-groups-portfolio-of-ip-as-proprietary-training-data-corpus-for-ai-initiatives-at-big-pharma/

 

We are publishing a Series of Five articles that demonstrate the Authentic Relevance of Five of the Ten Digital IP Asset Classes in LPBI Group’s Portfolio of IP for AI Initiatives at Big Pharma.

  • For the Ten IP Asset Classes in LPBI Group’s Portfolio, See

https://pharmaceuticalintelligence.com/portfolio-of-ip-assets/

The following Five Digital IP Asset classes are positioned as Proprietary Training Data and Inference for Foundation Models in Health care.
This Corpus comprises of Live Repository of Domain Knowledge Expert-Written Clinical Interpretations of Scientific Findings codified in the following five Digital IP ASSETS CLASSES:
 IP Asset Class I: Journal: PharmaceuticalIntelligence.com
6,250 scientific articles (70% curations, creative expert opinions.  30% scientific reports).
2.4MM Views, equivalent of $50MM if downloading an article is paid market rate of $30.

https://pharmaceuticalintelligence.com/vision/pharmaceuticalintelligence-com-journal-projecting-the-annual-rate-of-article-views/

 

 

• IP Asset Class II: 48 e-Books: English Edition & Spanish Edition.
152,000 pages downloaded under pay-per-view. The largest number of downloads for one e-Publisher (LPBI)
• IP Asset Class III: 100 e-Proceedings and 50 Tweet Collections of Top Biotech and Medical Global Conferences, 2013-2025

• IP Asset Class V: 7,500 Biological Images in our Digital Art Media Gallery, as prior art. The Media Gallery resides in WordPress.com Cloud of LPBI Group’s Web site

• IP Asset Class X: +300 Audio Podcasts: Interviews with Scientific Leaders
BECAUSE THE ABOVE ASSETS ARE DIGITAL ASSETS they are ready for use as Proprietary TRAINING DATA and INFERENCE for AI Foundation Models in HealthCare.
Expert‑curated healthcare corpus mapped to a living ontology, already packaged for immediate model ingestion and suitable for safe pre-training, evals, fine‑tuning and inference. If healthcare domain data is on your roadmap, this is a rare, defensible asset.
The article TITLE of each of the five Digital IP Asset Classes matched to AI Initiatives in Big Pharma, an article per IP Asset Class are:
  • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class I: PharmaceuticalIntelligence.com Journal, 2.5MM Views, 6,250 Scientific articles and Live Ontology

https://pharmaceuticalintelligence.com/2025/11/22/ai-initiatives-in-big-pharma-grog-prompt-proprietary-data-training-and-inference-by-lpbi-groups-ip-asset-class-i-pharmaceuticalintelligence-com-journal-2-5mm-views-6250-scientific-article/

 

  • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class II: 48 e-Books: English Edition & Spanish Edition. 152,000 pages downloaded under pay-per-view

https://pharmaceuticalintelligence.com/2025/11/22/ai-initiatives-in-big-pharma-grog-prompt-proprietary-training-data-and-inference-by-lpbi-groups-ip-asset-class-ii-48-e-books-english-edition-spanish-edition-152000/

 

  • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class III: 100 e-Proceedings and 50 Tweet Collections of Top Biotech and Medical Global Conferences, 2013-2025

https://pharmaceuticalintelligence.com/2025/11/22/ai-initiatives-in-big-pharma-grog-prompt-proprietary-training-data-and-inference-by-lpbi-groups-ip-asset-class-iii-100-e-proceedings-and-50-tweet-collections-of-top-biotech/

 

  • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class V: 7,500 Biological Images in LPBI Group’s Digital Art Media Gallery, as prior art

https://pharmaceuticalintelligence.com/2025/11/22/ai-initiatives-in-big-pharma-grog-prompt-proprietary-training-data-and-inference-by-lpbi-groups-ip-asset-class-v-7500-biological-images-in-lpbi-groups-digital-art/

 

  • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders

https://pharmaceuticalintelligence.com/2025/11/22/ai-initiatives-in-big-pharma-grog-prompt-proprietary-training-data-and-inference-by-lpbi-groups-ip-asset-class-x-300-audio-podcasts-library-interviews-with-scientific-leaders/

Conclusions by @Grok
Conclusions and Implications
LPBI Group’s IP Asset Class X: A Library of Podcasts are a “live repository” primed for Big Pharma AI, fueling from R&D reviews to global equity. Technical Implications: Enables auditory-multimodal models for diagnostics/education. Business Implications: Accelerates $500M ROI; licensing for partnerships. Unique Insight: As unscripted leader interviews, they provide a “verbal moat” in AI—completing series’ holistic pharma data ecosystem.Promotional with links to podcast library/IP portfolio. Synthesizes series by emphasizing auditory human-AI synergy.

In the series of five articles, as above, we are presenting the key AI Initiatives in Big Pharma as it was created by our prompt to @Grok on 11/18/2025:

  • What are PFIZER’s AI INITIATIVES?

@Grok Response:

x.com/i/grok/share/0ol5VOJsEYs11baXq4xkzNb0h

Generative AI tools that save scientists up to 16,000 hours annually in literature searches and data analysis.
Drug Discovery and Development Acceleration Pfizer uses AI, supercomputing, and ML to streamline R&D timelines
Clinical Trials and Regulatory Efficiency AI:

-Predictive Regulatory Tools

-Decentralize Trials

-inventory management

Disease Detection and Diagnostics:

–       ATTR-CM Initiative

–       Rare diseases

Generative AI and Operational Tools:

–       Charlie Platform

–       Scientific Data Cloud AWS powered ML on centralized data

–       Amazon’s SageMaker /Bedrock for Manufacturing efficiency

–       Global Health Grants:

Pfizer Foundation’s AI Learning Lab for equitable access to care and tools for community care

Partnerships and Education

–       Collaborations: IMI Big Picture for 3M – sample disease database

–       AI in Pharma AIPM Symposium: Drug discovery and Precision Medicine

–       Webinars of AI for biomedical data integration

–       Webinar on AI in Manufacturing

Strategic Focus:

–       $500M R&D reinvestment by 2026 targets AI for Productivity

–       Part of $7.7B cost savings

–       Ethical AI, diverse DBs

–       Global biotech advances: China’s AI in CRISPR

 

  • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders

The Left Column was written @Grok

The Right Column was written by Aviva Lev-Ari, PhD, RN

 

AI Initiative at Big Pharma

i.e., Pfizer

Library of Audio and Video Podcasts

N = +300

Generative AI tools that save scientists up to 16,000 hours annually in literature searches and data analysis.
Drug Discovery and Development Acceleration Pfizer uses AI, supercomputing, and ML to streamline R&D timelines Review ALL SCIENTIFIC BREAKTHROUGHS
Clinical Trials and Regulatory Efficiency AI:

-Predictive Regulatory Tools

-Decentralize Trials

-inventory management

Disease Detection and Diagnostics:

–       ATTR-CM Initiative

–       Rare diseases

Generative AI and Operational Tools:

–       Charlie Platform

–       Scientific Data Cloud AWS powered ML on centralized data

–       Amazon’s SageMaker/Bedrock for Manufacturing efficiency

–       Global Health Grants:

Pfizer Foundation’s AI Learning Lab for equitable  access to care and tools for community care

Ingest to Charlie Platform all +300 Podcasts
Partnerships and Education

–       Collaborations: IMI Big Picture for 3M – sample disease database

–       AI in Pharma AIPM Symposium: Drug discovery and Precision Medicine

–       Webinars of AI for biomedical data integration

–       Webinard on Ai in Manufacturing

Use Podcast for Education

Use Podcast as Hybrid: Start presentation with a Podcast continue with a life interview

Strategic Focus:

–       $500M R&D reinvestment by 2026 targets AI for Productivity

–       Part of $7.7B cost savings

–       Ethical AI, diverse DBs

–       Global biotech advances: China’s AI in CRISPR

 

CONCLUSIONS: The Voice of Dr. Stephen J. Williams PhD

PENDING

Article Summary by @Grok of the ArticleTitle:

AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders

Publication Date: November 22, 2025

Author/Curator: Aviva Lev-Ari, PhD, RN
(Curator; Posted by 2012pharmaceutical)
@Grok SOURCE:

Overview: Final (fifth) in LPBI Group’s five-article series on AI-ready digital IP assets for pharma. This installment highlights IP Asset Class X—+300 audio podcasts of interviews with scientific leaders—as a proprietary, expert-curated auditory corpus for training and inference in healthcare AI models. Using a November 18, 2025, Grok prompt on Pfizer’s AI efforts, it maps the library to pharma applications, emphasizing audio ingestion for breakthroughs review, education, and platform integration. Unlike visual/text prior classes, this focuses on verbal expert insights for multimodal/hybrid AI, positioning them as a “rare, defensible” resource for ethical, diverse foundation models.
Main Thesis and Key Arguments

  • Core Idea: LPBI’s +300 podcasts capture unscripted scientific discourse from leaders, forming a live repository of domain knowledge ideal for AI ingestion—enhancing Big Pharma’s shift from generic to human-curated models for R&D acceleration and equitable care.
  • Value Proposition: Part of ten IP classes (five AI-ready: I, II, III, V, X); podcasts equivalent to $50MM value in series benchmarks, with living ontology for semantic mapping. Unique for hybrid uses (e.g., education starters) and safe pre-training/fine-tuning, contrasting open-source data with proprietary, ethical inputs.
  • Broader Context: Caps series by adding auditory depth to text/visual assets; supports Pfizer’s $500M AI reinvestment via productivity gains (e.g., 16,000 hours saved).

AI Initiatives in Big Pharma (Focus on Pfizer) Reuses Grok prompt highlights, presented in an integrated mapping table (verbatim):

AI Initiative at Big Pharma i.e., Pfizer
Description
Generative AI tools
Save scientists up to 16,000 hours annually in literature searches and data analysis.
Drug Discovery and Development Acceleration
Pfizer uses AI, supercomputing, and ML to streamline R&D timelines.
Clinical Trials and Regulatory Efficiency AI
Predictive Regulatory Tools; Decentralize Trials; Inventory management.
Disease Detection and Diagnostics
ATTR-CM Initiative; Rare diseases.
Generative AI and Operational Tools
Charlie Platform; Scientific Data Cloud AWS powered ML on centralized data; Amazon’s SageMaker/Bedrock for Manufacturing efficiency; Global Health Grants: Pfizer Foundation’s AI Learning Lab for equitable access to care and tools for community care.
Partnerships and Education
Collaborations: IMI Big Picture for 3M-sample disease database; AI in Pharma AIPM Symposium: Drug discovery and Precision Medicine; Webinars of AI for biomedical data integration; Webinar on AI in Manufacturing.
Strategic Focus
$500M R&D reinvestment by 2026 targets AI for Productivity; Part of $7.7B cost savings; Ethical AI, diverse DBs; Global biotech advances: China’s AI in CRISPR.
Mapping to LPBI’s Proprietary DataCore alignment table (verbatim extraction, linking Pfizer initiatives to Class X podcasts):
AI Initiative at Big Pharma i.e., Pfizer
Library of Audio and Video Podcasts N = +300
Generative AI tools (16,000 hours saved)
(No specific mapping provided.)
Drug Discovery and Development Acceleration
Review ALL SCIENTIFIC BREAKTHROUGHS.
Clinical Trials and Regulatory Efficiency
(No specific mapping provided.)
Disease Detection and Diagnostics (ATTR-CM, rare diseases)
(No specific mapping provided.)
Generative AI and Operational Tools (Charlie, AWS, etc.)
Ingest to Charlie Platform all +300 Podcasts.
Partnerships and Education (IMI, AIPM, webinars)
Use Podcast for Education; Use Podcast as Hybrid: Start presentation with a Podcast continue with a life interview.
Strategic Focus ($500M reinvestment, ethics)
(No specific mapping provided.)

Methodologies and Frameworks

  • AI Training Pipeline: Ingest audio into Charlie/AWS for pre-training (expert discourse corpus), fine-tuning (e.g., breakthrough reviews), and inference (e.g., educational hybrids). Use ontology for thematic mapping; Grok prompt for sourcing initiatives.
  • Productivity Model: Boosts Pfizer’s $7.7B savings via auditory data for diverse, ethical AI (e.g., Learning Lab grants); hybrid formats for webinars/symposia.
  • Insights: Quote from Dr. Stephen J. Williams, PhD: Assets as “codified digital treasures” for safe healthcare AI. Predicts revolution in verbal inference for precision medicine.

Conclusions and Implications

LPBI Group’s IP Asset Class X:
A Library of Podcasts are a “live repository” primed for Big Pharma AI, fueling from R&D reviews to global equity. Technical Implications: Enables auditory-multimodal models for diagnostics/education. Business Implications: Accelerates $500M ROI; licensing for partnerships. Unique Insight: As unscripted leader interviews, they provide a “verbal moat” in AI—completing series’ holistic pharma data ecosystem.Promotional with links to podcast library/IP portfolio. Synthesizes series by emphasizing auditory human-AI synergy.
@Grok was prompted to summarize the Table of Contents of the e-Book that present the Library of Podcast INDEX.

Overview of IP Asset Class X: +300 Audio Podcasts – Interviews with Scientific LeadersThe BioMed Audio Podcast Library from LPBI Group is a valuable intellectual property asset in the biomedical field, featuring over 301 audio podcasts created from interviews, curations, and discussions with prominent scientific leaders. This collection highlights breakthroughs in areas like genomics, cancer research, immunology, precision medicine, and public health policy. Curated by experts such as Aviva Lev-Ari, PhD, RN (197 podcasts), Larry H. Bernstein, MD, FCAP (48 podcasts), and Stephen J. Williams, PhD (38 podcasts), the library is organized into 21 thematic chapters for easy navigation.Key features include:

  • Search and Accessibility: Filter by chapter, curator, subject, or podcast ID. Each entry includes text-to-speech conversion and NLP-generated WordClouds for topic visualization.
  • Content Focus: Emphasizes Nobel laureates, key opinion leaders, and innovators discussing technologies like CRISPR-Cas9, mRNA vaccines, immunotherapy, and biotechnology ventures.
  • Format and Updates: Derived from articles on real-time events (e.g., COVID-19 impacts, award announcements). The library continues to expand, with no direct audio embeds—access via linked articles for full transcripts and playback.
  • Themes Covered: Public health policy, cardiovascular science, neuroscience, academic institutions, and more, with a strong emphasis on translational research and personalized medicine.

This asset represents a rich repository for researchers, students, and professionals seeking insights from leaders like Francis Collins, Jennifer Doudna, and Siddhartha Mukherjee.Selected Highlights by ChapterBelow are curated examples from key chapters, showcasing interviews with scientific leaders. For the full library (301+ entries), visit the source page.

Chapter 1: Public Health
Podcast ID
Curator
Title
Scientific Leader(s)
Brief Description
Link
17
Aviva Lev-Ari
LEADERS in Genome Sequencing of Genetic Mutations for Therapeutic Drug Selection in Cancer Personalized Treatment: Part 2
Leaders in genome sequencing
Explores genetic mutations’ role in personalized cancer therapies.
161
Aviva Lev-Ari
FDA Commissioner, Dr. Margaret A. Hamburg on HealthCare for 310Million Americans and the Role of Personalized Medicine
Dr. Margaret A. Hamburg
Discusses personalized medicine’s impact on U.S. healthcare policy.
273
Aviva Lev-Ari
Live Notes and Conference Coverage in Real Time. COVID19 And The Impact on Cancer Patients Town Hall with Leading Oncologists; April 4, 2020
Leading oncologists
Real-time analysis of COVID-19’s effects on cancer care.
Chapter: Genomics & Genome Biology
Podcast ID
Curator
Title
Scientific Leader(s)
Brief Description
Link
23
Aviva Lev-Ari
2013 Genomics: The Era Beyond the Sequencing of the Human Genome: Francis Collins, Craig Venter, Eric Lander, et al.
Francis Collins, Craig Venter, Eric Lander
Reflections on post-human genome sequencing advancements.
226
Aviva Lev-Ari

Dr. Jennifer Doudna (UC Berkeley): PMWC 2017 Luminary Award, January 22, 2017

@PMWC

2017

Jennifer Doudna (CRISPR pioneer)
Award speech on CRISPR’s applications in biomedicine.
288
Aviva Lev-Ari
Allon Klein, Harvard Medical School, and Aviv Regev, Genentech, Recipients of National Academy of Sciences James Prize…
Allon Klein, Aviv Regev
Integration of science and technology in genomics research.
Chapter: Precision Medicine & Cancer (35+ Entries)
Podcast ID
Curator
Title
Scientific Leader(s)
Brief Description
Link
15
Aviva Lev-Ari
Harnessing Personalized Medicine for Cancer Management, Prospects of Prevention and Cure: Opinions of Cancer Scientific Leaders
Cancer scientific leaders
Expert opinions on preventing and curing cancer via personalization.
12
Aviva Lev-Ari
The “Cancer establishments” examined by James Watson, co-discoverer of DNA w/Crick, 4/1953
James Watson (Nobel laureate)
Critique of cancer research institutions by DNA co-discoverer.
132
Aviva Lev-Ari
Practicing Oncology: Medscape Editor-in-Chief Eric J. Topol, MD interviews Siddhartha Mukherjee, MD, PhD
Siddhartha Mukherjee (interviewed by Eric J. Topol)
Insights into oncology practices and patient care.
102
Aviva Lev-Ari
Reuben Shaw, Ph.D., a geneticist and researcher at the Salk Institute: Metabolism Influences Cancer
Reuben Shaw, Ph.D.
How metabolism drives cancer progression.
209
Aviva Lev-Ari
Pioneers of Cancer Cell Therapy: Turbocharging the Immune System to Battle Cancer Cells…
Immunotherapy pioneers
Advances in CAR-T and immune-based cancer therapies.
This selection captures the library’s depth, blending historical perspectives (e.g., Watson) with cutting-edge topics (e.g., CRISPR, immunotherapy). For deeper dives, use the site’s search tools to explore chapters like Cardiovascular Science (36 podcasts) or Immunology.

Read Full Post »

17th Annual EmTech @ Media Lab, MIT – November 7 – 8, 2017, Cambridge, MA – This Year’s Themes, Speakers and Agenda

Article ID #243: LIVE Day Two and Day One – 17th Annual EmTech @ Media Lab, MIT – November 7 – 8, 2017, Cambridge, MA – This Year’s Themes, Speakers and Agenda. Published on 9/8/2017

WordCloud Image Produced by Adam Tubman

MIT Media Lab
Building E14
75 Amherst Street 
(Corner of Ames and Amherst)

Themes:

  • Business Impact
  • Connectivity
  • Intelligent Machines
  • Rewriting Life
  • Sustainable Energy
  • Meet the Innovators Under 35

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

pharma_bi-background0238

will cover in REAL TIME

The 17th annual EmTech MIT – A Place of Inspiration, November 7 – 8, 2017, Cambridge, MA

 

MIT Technology Review’s EmTech conference

 

In attendance, covering LIVE using Social Media

Aviva Lev-Ari, PhD, RN

Editor-in-Chief

http://pharmaceuticalintelligence.com

@pharma_BI

@AVIVA1950

#emtechmit

@techreview

 

https://events.technologyreview.com/emtech/17/?utm_medium=email&utm_source=press_list&utm_campaign=emtech2017&utm_term=conference&utm_content=press_credentials&discount=MEDIAM172B#section-about

 

AGENDA FOR TUESDAY, NOVEMBER 7, 2017

  • 8:00
    Registration & Breakfast
9:00
Opening Remarks – Elizabeth Bramson-Boudreau, MIT TR
  • In Media Lab – MIT and MIT Technology Review was established in 1899
  • EmTech 1999 – 100 years to MIT Technology Review
  • Innovations and pushing the boundaries
  • AI – potential and limitations
  • Climate change requires new technologies
  • Brain Technologies: Biology Vision
  • Tomorrow: emerging technologies: Cybercrime, role of technology
  • Automation and future of work
  • Partners: GE, Lamburghini
  • Lemelson-MIT
  • MITTR – Whova on AppleStore
 
9:15
The State of AI – Andrew Ng, CS.AI, Stanford University – was 2008 Young Innovator,
Founder, Deeplearning.ai; Adjunct Professor, Stanford University
 
  • Trends in AI – AI is the new Electricity
  • Deep Learning & Neural Networks (NN):
  1. Input a picture –>> output: Is it You?
  2. loan application outcome: will you repay (%)
  3. picture from car – Output GPS address –>> Supervised Learning
  4.  doing act in <1 sec of thinking
  5. training SMALL, Medium size very large NN
  6. Algorithm innovations:

Supervised Learning algorithm types:

  • Transfer Learning
  • Unsupervised learning
  • Reinforcement learning – hunger for data: i.e., robotic applications

Importance of Data accumulation for launch a Product –  Users — data growth

  • Shopping Mall + website is not equal an Internet company
  • Internet company:
  1. push data to CEOs
  2. A–B Testing
  3. Short cycle time
  4. Decisions made by PM and ERP

AI era

traditional company + NN not equal AI company

  • Strategic data acquisition
  • Unified data warehouse
  • NEW JOB DESCRIPTIONS
  • Precision automation
  • ORGANIZATION CHART to interface in a matrix with AI Teams – hire Ai in the Business Units
  • Scarce talent of AI

Discussion

  • Children MUST learn to code
  • Human-Computer communication will be by writing code
9:45
Meet the Innovators Under 35
  • Future of work
  • warranted reliant digital connectivity
 
10:30
Break & Networking
 
11:00
AI’s Next Leap Forward

Tomasso Poggio, MIT, CSAIL, BCS

  • Deep learning  – next step
  • Bet on Center Brain Mind Machines (CBMM)
  • Josh Tennenbaum at MIT
  • Autonomous Driving – Amnon Shaashua, MobilEye
  • 20 years @ MI AI: Dailmer and MIT — detection of pedestrans
  • Powerful computers and algorithms – Reinforcement Learning Networks (Brain Science), models of Vision and Deep Learning Networks – WHEN they work?
  • Building Jarvis – a buttler application in AI built by Marc Zukenberg
  • NeuroScience – MobilEye, AlphaGo
  • CBMM – NSF $50 Million in AI funding  – Science of Intelligence and Engineering of Intelligence
  • MIT & Harvard plus several organization
  • Business Partners: MS Soft, Google bought MobilEye,
  • Center for Visual Gaze – 200 msec of visual processing
  • ERGO SUM: toward symbols, Cognitive core, visual system, Brain OS – running routines
  • Breakthroughs: Theory: under which conditions,
  1. Learning theory
  2. optimization Approximation Theory: Deep vs Shallow networks
  3. Intelligence is greatest problem to solve it is like LIFE, Tomasso Poggio, MIT, CSAIL, BCS
  4. machine can help human to think better, long time horizon is needed,

Kris Hammond, Prof. Northtwestern University

  • Data analytics and Ideas
  • words vs language – past, present, future – uniquely HUMAN, now machine language is Human Partner
  • language vs Ideas
  • machines knows a lot
  • facts, dat move to narrative
  • Language is understanding
  • FIN information: Decisions about allocations,
  • Turbidity data on the beach in Chicago: Which Beach is the cleanest vs the dirtiest
  • NARRATIVE ANALYTICS: data that machine can tell us what it has as a story and presented as intelligent language,

    Cognitive Science application to autonomous driving – Yibio Zhau, Tennenbaum Lab @MIT, ISEE.AI, Computer vision, Cognitive Science

  •  interpulate and extrapulate data needed for autonomous driving
  • reasoning beyond the system: Human intelligence , intentional reasoning, pattern recognition,
  • Ali baba – funding building of a Robot for autonomous driving – understanding by imagining – causes for behavior by others
  • ISEE – Next generation of AI — driving drivessless ly for thousands of miles
  • Car to car communication is a sensoring issue, negotiation need to be taught to machines

Young Scientists 35 years old or less

Austin Olson, Luminar – object detection 99% accuracy,

Angella Schoellig — Roborts, Prof. University of Toronto, robots in predictable environments

Lorenz Meier — Vertical Technologies – Drones and safety – DB of flights

12:30
Lunch & Networking
2:00
Adapting to the reality of climate change

Lee Krevat, Sempra –

owns Wind Farms- managing a Grid with renewable energy. Variable – Wind technology wind is variable – if wind blows too much switch to diesel. 100% renewable for one hour on Islands

 
Growth area:
  1. 20 cents diesel, wind is 10 cents help the enviroment

mainland, not yet used, price diesel vs wind

Solar wind generation – next biggest Technology in Energy

 
and
 

Alex Tepper,Avetars

Robotics, Drones, AI and the Future of Energy – A start up incubator sponsored and funded by GE
  • RAIL – Predict derailments
  • OIL & GAS – corrosion is the enemy — knowledge of corosion progression – using AI algorithms

Growth area: Aviation

John Holdren – Harvard University – Government  Role in ENERGY and Climate Change – Obama’s advisor Presidential CSO on Climate and energy

  • mitigation
  • adaptation
  • suffering – shortcomings of mitigation and adaptation
  • harm of business as usual
  • Efficiency standards during Obama Administration, assistance to other countries led to the Agreement in Paris 195 countirs — agreement to reduce emission. China and US declare cooperation on emission of gases into the environment.
  • PRESIDENT TRUMPS CALLED CLIMATE CHANGE A HOAX  – proposed to cut energy R&D
  • All executive orders by Obama – were reverted by Trump
  • Innovations: Electricity from Solar increase and wind as well and batteries
  • Carbon capture and storage – technological challenge
  • Biofuel processing, liquid bio fuel
  • Nuclear innovations to nuclear waste
  • 2100 – 5% on defense and 2% on the environment – model under estimate the contribution of innovations for the long run.
  • 1000 businesses in deployment of technologies

Evelyn wang, MIT – Material Science – Sustainable energy – nano

  • material properties: superior properties of LOW DENSITIES
  • Light manipulation
  • membrane
  • CO2 capture
  • Technologies: Nnao, Thermoelectronics, energy and water
  • Solar 6% and wind 21%, biomass 5%voltaic
  • SOlar eneconversion
  • PHOVOLTAIC: SCALBALE, SOLID STATE, INTERMITTENT, PARTIAL SOLAR SPECTRUMrgy
  • Nanophotonics: Solar energy conversion: photo
  • Nano absorber – area ratio; Emitter: silicon and silicon  – spectral approach
  • potential STPVs
  • Transportation using energy with emission
  • Power consumed by HVAC
  • Thermal Battery for Electric Vehicle: Adsorption Heating and Cooling
  • Desorption vs Adsoption: cooling vs Heating mode
  • High capacity adsobents – Zeolite  MOF enhancing capacity heat and mass transport
  • Tmal Battery Prototype: Hybrid, electric, stationary domestic HVAC.
  • Water harvesting from Air – metal organic Frameworks: Adsorption – harvest water without need of additional electricity
  • Opportunities for Advanced Materials

Prof. David Keith, Harvard University

  • technologies to stop global changing
  • research program
  • stratospheric aerosol cool planet – pollution masking global warming
  • solar geo-engineering, vs emission cut 3x BAU vs business as usual
  • Annual maximal Temperatures, extreme precipitation,
  • carbon emission worm up vs climate risk in Time
  •  use of technology for climate change mitigation: carbon removal
  • Solar engineering is the solution
 
3:30
Break & Networking
4:00
Meet the Innovators Under 35
 

Next Generation Brain Interfaces

Andrew Schwartz, University of Pittsburg

  • Causality is obscure
 
5:30
Lemelson-MIT Prize Honors & Reception
 
Lemelson-MIT Prize Honors Feng Zhang, MIT with the Prize for contributions to CRISPR Applications as a therapeutics method in genomics
 
 

AGENDA FOR WEDNESDAY, NOVEMBER 8, 2017

  • 8:00
    Registration & Breakfast
9:00 Elizabeth Branson
 
9AM – 9:30AM Robots and AI in Everyday Life

Daniela Rus, CSAIL, MIT – Robots: drones, 3D Printing

hosted by David Rotman, MIT TR

  • supply chain and transportation – city will benefit from a different business model
  • autonomous driving deployed in Singapore
  • all vehicles on wheels can be made autonomous
  • blind – camera on a belt assists in navigation
  • ML: Patterns and predictions
  • AI – reasoning
  • robots: motion
  • Machine read entire libraries
  • Radiology: Read by machines vs by Radiology: AI  + Human — 0.5% error
  • Rural area medicine
  • Machines – Better Lawyers: NLP – read precedents to cases, machines can’t write a briefing or defend a plaintif
  • Factory and Automation: Robots roles – enable mass OPTIMIZATION  not only mass production
  • Machines do not have common sense and do not have ability to reason
  • crunching data vs analysis
  • JOB Categories:Tasks vs Professions: Routine data processing and labor task — are ready for automation
  • NEW jobs: User experience designer, GPS enable taxi drivers to drive and drove pay scale down
  • GDP – decreased 1966 – 2016
  • KY school to train coal miners to do data processing to become CODERS
  • JFK – new machines brings man back to jos – new jobs
  • AI supports NEW jobs: CS/AI part of literacy
  • people and machines – in collaboration

discussion

  • Who to make the transition?
  • CODING is key – people must be active in keeping up and continue to train
  • make it easy to make machines, interactions Man-Machine easier,
  • YOU ARE WRONG SIGNAL IS recognized by EEG
  • AI and Future of Work Conference at MIT – anxiety related to job changing due to technology
  • Technology can’t solve all problems, Technology helps, Technology implications on Policy – technology as a unifier societal force not a dividers
  • Transportation as Utility
 

9:30 – 10:00 AI and the Future of Work

Iyad Rahwan, MIT Media Lab, Introduction by Elizabeth Woyke, TR

  • Physical Therapist — will not be replaced by computerisation
  • Probability of computerisation: Skilled cities are better at economics shocks
  • Adam Smith – simple operations
  • Differential Impact from Automation on Cities – the larger the city more resilient to automation
  • City size vs clusters of occupations — cluster grow with city size
  • Impact on Middle Class vs Lower and Upper: low paying jobs, middle and high
  • Skills in Occupations: mapping SkillScape correlations with Education
  • Skills in demand

discussion

  • Urbanization took place – 80% live in cities around the World
  • Outliers in CIties by size and Skills: Boulder, CO – small size very skilled labor, politics support start ups and high tech

10AM – 10:30AM

Meet the Innovators Under 35

  • Tracy Chou – ProjectInclude – diversity
  1. All about data
  • Olga Russakovsky – Princeton University – Computer vision
  • AI for education of under privileged high school
  1. IM-GENET – Data sets encode human biases
  2. AI is powered by Data
  3. AI learns societal  biases
  4. Researchers shape AI
  • 10:30

    Break & Networking

     
  • 11:00 – 11:30 What is Social Media Doing to Society?
 Yasmin Green, Jigsaw, Google
  • 300 million reach of Ads posted by Google in the Internet
  • Fake news
  • Network shape
  • Veracity and popularity personalized
Hosted by Martin Giles, TR
 
  • e 11:30 – 11:45 Meet the Innovators under 35
  • Phillipa Gill  – UMass CS – Project of Network measurement on censorship measurement platforms
  • Joshua Browder – DoNotPay

11:45 – 12:00 The Emerging Threat of Cybercriminal AI

Shuman Ghosemajumder, Shape Security

Hosted by Martin Gile

  • CyberCrime is evolving using AI – Imitation Game – Turing Test restricted Turing Tests
  • Computer vision, Solving CAPUTRE – Copletely Automated Turing  Tests
  • CAPTCHA by Google
  • Credential Stuffing Accounts Attacks – SONY was hacked and 93,000 Passwords stolen
  • Clip Farms at Google
  • BLACKFISH – identify Credential Stuffing Accounts Attacks, all invalid password are not valid to be used by cyber attackers again – that authentication is no longer valid
  • Multi Factors Authentications vs ease of use to Log In
  • Knowledge Basis – Probabilistic  SYmbols – BlackFISH – technological advantage – iPhone stores a math formulation of characteristics of the finger print not the image of the fingure
  •  12:00
    Lunch & Networking – Lamborghini -super sport car
     
1:30 – 2PM
Technology Spotlight: Mind-Controlled VR
Ramses Alcaide, Neurable
Hosted by Rachel Metz, TR
  • Killer Platforme ==>Killer Interaction ==>Killer application
  • Reactive ==> Proactive
  • Brain Computer Interaction (BCI) – maximum Privacy no voice involved like in SPeech
  • Voice, Motion Tracking, eye tracking
  • Human intentionality – a World without limitations
  • NASA is a client
  • consol technology for navigation, typing,
  • Problems: Add to glasses or as an Ear piece
  • the signal is ACTION POTENTIAL
  • latency differences between individuals
  • Non-invasive to invasive to capture signals
 
2:00 – 2:30 Capturing Our Imagination:: Evolution of Brain-Machine Interfaces
Mary Lou Jepsen, Openwater
Hosted by Antonio Ragalado, TR
  • Using functional MRI technology for a NEW device to scan emotions rather than medical diseases
  • HOLOGRAPHY of the Brain – liquid crystal display is like transistors on a chip
  • OPTICS – DISCONTINUITY of Moore’s law – high resolution like functional MRI
  • Holographic LCD – scattering material VOXEL detector – measure intensity of light, no resolution, consumer camera speed OK Inexpensive
  • Human body scattering
  • HAT and Bandage
 
2:30 – 3PM Future of Work – REWARD DISOBEDIENCE –
 
New Prize of $250,000  – Ethics and governance in AI at MIT Media lab
 
Reid Hoffman, Greylock Partners Founder LinkedIn
conversation with Joi Ito, MIT Media Lab
  • Tell the Truth
  • Media Lab — a Non-disciplinary place
  • Universities play a role in Social Justice
  • FEAR of AI:
  1. For profit will own it all
  2. stupid AI will govern
  3. displace work
  4. espionage
  5. catalytic institute that will make a contribution to OPENNESS vs technological dominance

Joi Ito, MIT Media Lab: AI problems –

  • MUST be democratized – Now it is in the hands of very FEW
  • RISK SCORES can’t be contested in court because they are IP of for profit companies
  • Joi Ito, MIT Media Lab at MIT do good to Society vs make the most of money which the majority are doing
  • AUTONOMICH vs autonomous agents, said Joi Ito, MIT Media Lab – Hoffman: Design goals more symbiotic: Scaling, more productive, Season 2 launched today
  • Design principle – LEARNING vs EDUCATION, Joi Ito, MIT Media Lab

Hoffman on AI Technologies

  • shaping it to avoid catastrophic negatives
  • provide a public good via participation
3:00
Break & Networking
 
3:30 – 4 Big Problems, Big Data Solutions
Deb Roy, MIT media Lab
 
  • Tweets and News, Washington Post – Tracking tweets from US on Politics related to the Elections
  • National memory on Guns, Immigrations
  • Debate brief from tweets and News rooms
  • topic classifier,  Campaign finance, SHARE OF COVERAGE IN NEWS, SHARED OF VOICE ON TWITTER
  • deep neural network training algorithms
  • Passion Gap: cut data on Twitter – Trump supporters exhibited x2 fold energy vs the Democratic candidate
  • How does Media flow: Sanders, Clinton, Trump – each is a Media Source
  • Truth, Trust, Attention  – Fact checking
  • If Trust the source then I believe it is True
  • Public Opinion: The Politics of Resentment in Rural WI – Katherine Cramer
  • Listening Networks: Human- Human Interaction: Media sharing network – change week by week – the MOST innovative methodology developed to date for Public Opinion – presentation by
    Deb Roy, MIT media Lab  – using deep Neural network training
     
  1. main stream
  2. conservative
  3. liberal activist
  • Health Indicators:
  • Shared attention
  • Shared Reality
  • Varied Perspective – surface under-heard voices
3:30 – 4
Meet the Innovators Under 35
 
1. Svenja Hinderer, Germany
  • Valve – development of Tissues, biochemical properties
  • signaling molecules
  • mechanical strength – physiological
  • Attrach stem cells – proper matrix formation
  • Functional implants
 
2. Viktor Adalsteinsson
  • Cancer Precision medicine – Liquid biopsy – tumor mutations
  • entire Cancer Genome – from blood biopsy
  • Scaling: Broad Institute 100 collaborators – 3,000 blood sample genomical analysis
 
 
2.Tallis Gomes, CEO Entrepreneur, Brazil
  • Easy Taxi
  • Fighting inequality
  • 15Billion – Beauty Market
 
 
3. Abidigani Diriye
  • IBM Research Africa – 300 million adults – lack of access to financial services
  • Univesities, Government  – start ups to scale ideas
 
 
Eyad Janneh
 
  • 5:00
    2017 Innovator Under 35 Awards & Reception
  1. Speakers
    • Viktor
      Adalsteinsson

      Group Leader, Broad Institute of MIT and Harvard

      2017 Innovator Under 35

    Gene
    Berdichevsky

    CEO, Sila Nano

    2017 Innovator Under 35

    • rechargeable battery
    • new class of materials charge and discharge in battery
    • store more energy
    • more better designed electronics: electrified flight, solar, car: Hybrid and electric
    • 21st Century belongs to electrification vs combustion in the 20th century,

      Gene
      Berdichevsky

      CEO, Sila Nano

    • Tracy
      Chou

      Founding Advisor, Project Include

      2017 Innovator Under 35

    • Adrienne
      Felt

      Software Engineer, Google

      2017 Innovator Under 35

    • Phillipa
      Gill

      Assistant Professor, University of Massachusetts, Amherst

      2017 Innovator Under 35

    • Tallis
      Gomes

      CEO, Singu

      2017 Innovator Under 35

    Kathy
    Gong

    CEO, WafaGames

    2017 Innovator Under 35

    • GAMING SWARD OF GLORY – EPIC NEW RTS EXPERIENCE – WAFA GAMES IN CHINA
    • Ian
      Goodfellow

      Staff Research Scientist, Google Brain, development occurred at OpenAI

      GAN’s – Generative Adversarial Network – from AI Optimization to Game Theory

      2017 Innovator Under 35

    • Yasmin
      Green

      Director of Research and Development, Jigsaw at Google

      Addressing Online Threats to Global Security

    • Kris
      Hammond

      Chief Scientist and Cofounder, Narrative Science

      AI’s Language Problem

    • Svenja
      Hinderer

      Scientist, Fraunhofer IGB

      2017 Innovator Under 35

    • Reid
      Hoffman

      Cofounder, LinkedIn; Partner, Greylock Partners

      The Future of Work

    • John
      Holdren

      Professor, Harvard University

      Climate Disruption: Technical Approaches to Mitigation and Adaptation

    • Joi
      Ito

      Director, MIT Media Lab

      The Future of Work

    • Mary Lou
      Jepsen

      Founder, Openwater

      Capturing Our Imagination: The Evolution of Brain-Machine Interfaces

    • David
      Keith

      Professor, Harvard University; Founder, Carbon Engineering

      The Growing Case for Geoengineering

    • Neha
      Narkhede

      Cofounder and CTO, Confluent

      2017 Innovator Under 35

    • Andrew
      Ng

      Founder, Deeplearning.ai; Adjunct Professor, Stanford University

      The State of AI

    • Tomaso
      Poggio

      Investigator, McGovern Institute; Eugene McDermott Professor, Brain and Cognitive Sciences, MIT

      Understanding Intelligence

    • Olga
      Russakovsky

      Assistant Professor, Princeton University

      2017 Innovator Under 35

    Michael
    Saliba

    Marie Curie Fellow, EPFL

    2017 Innovator Under 35

    • disruptive technology in the energy space
    • Gang
      Wang

      Chief Scientist, Alibaba

      2017 Innovator Under 35

    • Jianxiong
      Xiao

      Chief Executive Officer, AutoX, Inc.

      2017 Innovator Under 35

      CAMERA-first solution affordable self-driving

  2.  

Read Full Post »